HDAC6:瘤的进展和超越
João Marcos Oliveira-Silva1,2, Leilane Sales de Oliveira1,2, João Vitor Marangoni Tagliéri1
1Human Genetics Laboratory, Institute of Natural Sciences, Federal University of Alfenas (UNIFAL-MG), Alfenas, 37130-001, MG, Brazil.
基因组脱酸酶6 (HDAC6) 是一个有前途的癌症标,因为它的细胞质作用和非基因组标. HDAC6抑制剂在治疗各种癌症方面显示出潜力,并在临床试验中取得进展.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 基因组脱酶6 (HDAC6) 在HDAC中是独一无二的,主要位于细胞质中.
- 它拥有两个催化域和一个独特的泛素结合域.
- HDAC6脱乙化非希斯基质,如α-tubulin,HSP90和cortactin. 这类基质是非希斯基质.
研究的目的:
- 审查HDAC6.6的结构特征.
- 阐明HDAC6在瘤进展中的生物学功能.
- 讨论HDAC6抑制剂在癌症治疗中的治疗潜力.
主要方法:
- 审查关于HDAC6结构和功能的现有文献.
- 对HDAC6在关键癌症特征中的作用的分析.
- 来自HDAC6抑制剂的临床前和临床试验数据的汇编.
主要成果:
- HDAC6影响瘤入侵,转移,血管生成,药物耐药性,干性和免疫逃避.
- 选择性HDAC6抑制剂正在针对固体和血液瘤进行研究.
- 几种HDAC6抑制剂已经进入临床试验,初步结果是积极的.
结论:
- 在瘤学中,HDAC6是重要的治疗点.
- 准HDAC6为癌症治疗提供了一个有希望的策略.
- 目前正在进行的临床试验正在评估HDAC6抑制剂的疗效.
更多相关视频
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
相关概念视频
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
